Revvity Inc (RVTY)

Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell

$96.12

Buy

$100.73

arrow-up$7.25 (+7.95%)

Prices updated at 12 May 2025, 21:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD
PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics.
S&P 500
arrow-up3.26%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Alexis P. Michas
CEO
Dr. Prahlad R. Singh, PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
11,000
Head office
77 4th Avenue
Waltham
United States
02451
mobile
+1 781 663-6900
letter
-
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Alexis P. Michas
Non-Executive Chairman of the Board
0.18m
Mr. Joel S. Goldberg
Senior Vice President, Administration, General Counsel and Secretary
0.55m
Dr. Peter Barrett,PhD
Independent Director
0.11m
Mr. Tajinder Vohra
Senior Vice President, Global Operations
0.48m
Dr. Sophie V. Vandebroek, PhD
Independent Director
0.08m
Dr. Frank R. Witney,, PhD
Independent Director
0.09m
Ms. Pascale Witz, M. Sc.,M.B.A.
Independent Director
0.09m
Mr. Michel Vounatsos
Independent Director
0.11m
Dr. Prahlad R. Singh, PhD
Director, President and Chief Executive Officer
1.10m
Mr. Samuel R. Chapin
Independent Director
0.12m
Ms. Miriame Victor
Senior Vice President and Chief Commercial Officer
0.47m
Mr. Michael A Klobuchar
Independent Director
0.08m
Dr. Michelle McMurry-Heath, PhD
Independent Director
0.09m
Mr. Maxwell Krakowiak
Senior Vice President and Chief Financial Officer
0.51m
Ms. Anita Gonzales
Vice President and Controller
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
T. Rowe Price Investment Management,Inc.20,761,308
Vanguard Group Inc14,290,211
T. Rowe Price Capital Appreciation Fund14,181,064
Janus Capital Management LLC8,968,374
BlackRock Inc8,689,777

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
16 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
09 Oct 2024-
09 Oct 2024-
07 Oct 2024-
08 Oct 2024-
08 Oct 2024-
07 Oct 2024-
16 Sep 2024-
15 Aug 2024-
07 Aug 2024-
07 Aug 2024-
07 Aug 2024-
07 Aug 2024-
17 Jun 2024-
07 Jun 2024-
07 Jun 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.